{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:48:12Z","timestamp":1785250092230,"version":"3.55.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Ward Excellence Clinical Research Program of Beijing","award":["BRWEP2024W014090210"],"award-info":[{"award-number":["BRWEP2024W014090210"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05519-9","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T09:43:49Z","timestamp":1774431829000},"page":"2729-2739","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular characteristics of apolipoprotein M and its biological functions in kidney diseases"],"prefix":"10.1007","volume":"481","author":[{"given":"Jingjin","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"issue":"23","key":"5519_CR1","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.120.044221","volume":"143","author":"A Rohatgi","year":"2021","unstructured":"Rohatgi A et al (2021) HDL in the 21st century: a multifunctional roadmap for future HDL research. Circulation 143(23):2293\u20132309","journal-title":"Circulation"},{"issue":"8","key":"5519_CR2","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1194\/jlr.R034025","volume":"54","author":"MC Phillips","year":"2013","unstructured":"Phillips MC (2013) New insights into the determination of HDL structure by apolipoproteins: thematic review series: high density lipoprotein structure, function, and metabolism. J Lipid Res 54(8):2034\u20132048","journal-title":"J Lipid Res"},{"issue":"8","key":"5519_CR3","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1194\/jlr.M600055-JLR200","volume":"47","author":"C Christoffersen","year":"2006","unstructured":"Christoffersen C et al (2006) Isolation and characterization of human apolipoprotein M-containing lipoproteins. J Lipid Res 47(8):1833\u20131843","journal-title":"J Lipid Res"},{"issue":"44","key":"5519_CR4","doi-asserted-by":"publisher","first-page":"31286","DOI":"10.1074\/jbc.274.44.31286","volume":"274","author":"N Xu","year":"1999","unstructured":"Xu N, Dahlb\u00e4ck B (1999) A novel human apolipoprotein (apoM). J Biol Chem 274(44):31286\u201331290","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"5519_CR5","doi-asserted-by":"publisher","first-page":"143187","DOI":"10.1016\/j.ijbiomac.2025.143187","volume":"310","author":"R Yadav","year":"2025","unstructured":"Yadav R, Obinata H, Venkataraman K (2025) Delineating the intricacies of polymorphisms, structures, functions and therapeutic applications of biological high-density lipoprotein-apolipoprotein M: a review. Int J Biol Macromol 310(Pt 2):143187","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"5519_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10456-025-09975-7","volume":"28","author":"B Jung","year":"2025","unstructured":"Jung B et al (2025) ApoM-bound S1P acts via endothelial S1PR1 to suppress choroidal neovascularization and vascular leakage. Angiogenesis 28(2):24","journal-title":"Angiogenesis"},{"issue":"7560","key":"5519_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nature14462","volume":"523","author":"VA Blaho","year":"2015","unstructured":"Blaho VA et al (2015) HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation. Nature 523(7560):342\u2013346","journal-title":"Nature"},{"issue":"11","key":"5519_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s41581-024-00864-8","volume":"20","author":"MSY Ng","year":"2024","unstructured":"Ng MSY et al (2024) Drug repurposing for glomerular diseases: an underutilized resource. Nat Rev Nephrol 20(11):707\u2013721","journal-title":"Nat Rev Nephrol"},{"key":"5519_CR9","doi-asserted-by":"crossref","unstructured":"KDIGO (2024) Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105(4s):S117\u2013s314","DOI":"10.1016\/j.kint.2023.10.018"},{"issue":"2","key":"5519_CR10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s10753-018-0918-0","volume":"42","author":"Z Zheng","year":"2019","unstructured":"Zheng Z et al (2019) ApoM-S1P modulates Ox-LDL-induced inflammation through the PI3K\/Akt signaling pathway in HUVECs. Inflammation 42(2):606\u2013617","journal-title":"Inflammation"},{"issue":"1","key":"5519_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1078\/0065-1281-00687","volume":"105","author":"XY Zhang","year":"2003","unstructured":"Zhang XY et al (2003) Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization. Acta Histochem 105(1):67\u201372","journal-title":"Acta Histochem"},{"issue":"2","key":"5519_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.acthis.2003.11.004","volume":"106","author":"XY Zhang","year":"2004","unstructured":"Zhang XY et al (2004) Expression pattern of apolipoprotein M during mouse and human embryogenesis. Acta Histochem 106(2):123\u2013128","journal-title":"Acta Histochem"},{"issue":"6","key":"5519_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.bbalip.2017.03.003","volume":"1862","author":"AC Kober","year":"2017","unstructured":"Kober AC et al (2017) Implications of cerebrovascular ATP-binding cassette transporter G1 (ABCG1) and apolipoprotein M in cholesterol transport at the blood-brain barrier. Biochim Biophys Acta Mol Cell Biol Lipids 1862(6):573\u2013588","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"4","key":"5519_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00018-009-8764-8","volume":"66","author":"B Dahlb\u00e4ck","year":"2009","unstructured":"Dahlb\u00e4ck B, Nielsen LB (2009) Apolipoprotein M affecting lipid metabolism or just catching a ride with lipoproteins in the circulation? Cell Mol Life Sci 66(4):559\u2013564","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"5519_CR15","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1210\/me.2005-0209","volume":"20","author":"K Faber","year":"2006","unstructured":"Faber K et al (2006) Megalin is a receptor for apolipoprotein M, and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M. Mol Endocrinol 20(1):212\u2013218","journal-title":"Mol Endocrinol"},{"key":"5519_CR16","doi-asserted-by":"publisher","first-page":"1328259","DOI":"10.3389\/fphar.2024.1328259","volume":"15","author":"LS Bisgaard","year":"2024","unstructured":"Bisgaard LS et al (2024) Kidney derived apolipoprotein M and its role in acute kidney injury. Front Pharmacol 15:1328259","journal-title":"Front Pharmacol"},{"issue":"1\u20132","key":"5519_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0014-5793(01)02544-3","volume":"499","author":"J Duan","year":"2001","unstructured":"Duan J, Dahlb\u00e4ck B, Villoutreix BO (2001) Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis. FEBS Lett 499(1\u20132):127\u2013132","journal-title":"FEBS Lett"},{"issue":"4","key":"5519_CR18","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jmb.2009.08.071","volume":"393","author":"M Sevvana","year":"2009","unstructured":"Sevvana M et al (2009) Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M. J Mol Biol 393(4):920\u2013936","journal-title":"J Mol Biol"},{"issue":"8","key":"5519_CR19","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1194\/jlr.M700103-JLR200","volume":"48","author":"J Ahnstr\u00f6m","year":"2007","unstructured":"Ahnstr\u00f6m J et al (2007) Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M. J Lipid Res 48(8):1754\u20131762","journal-title":"J Lipid Res"},{"issue":"23","key":"5519_CR20","doi-asserted-by":"publisher","first-page":"9613","DOI":"10.1073\/pnas.1103187108","volume":"108","author":"C Christoffersen","year":"2011","unstructured":"Christoffersen C et al (2011) Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci U S A 108(23):9613\u20139618","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5519_CR21","doi-asserted-by":"publisher","first-page":"30655","DOI":"10.1038\/srep30655","volume":"6","author":"H Zhang","year":"2016","unstructured":"Zhang H et al (2016) Binding characteristics of sphingosine-1-phosphate to ApoM hints to assisted release mechanism via the ApoM calyx-opening. Sci Rep 6:30655","journal-title":"Sci Rep"},{"issue":"4","key":"5519_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00109-005-0030-4","volume":"84","author":"VI Zannis","year":"2006","unstructured":"Zannis VI, Chroni A, Krieger M (2006) Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J Mol Med (Berl) 84(4):276\u2013294","journal-title":"J Mol Med (Berl)"},{"issue":"4","key":"5519_CR23","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nm1211","volume":"11","author":"C Wolfrum","year":"2005","unstructured":"Wolfrum C, Poy MN, Stoffel M (2005) Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med 11(4):418\u2013422","journal-title":"Nat Med"},{"issue":"3","key":"5519_CR24","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1194\/jlr.M002162","volume":"51","author":"A Mulya","year":"2010","unstructured":"Mulya A et al (2010) Apolipoprotein M expression increases the size of nascent pre beta HDL formed by ATP binding cassette transporter A1. J Lipid Res 51(3):514\u2013524","journal-title":"J Lipid Res"},{"issue":"5","key":"5519_CR25","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1074\/jbc.M113.499913","volume":"289","author":"M Liu","year":"2014","unstructured":"Liu M et al (2014) Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM\/sphingosine 1-phosphate-enriched plasma high density lipoprotein. J Biol Chem 289(5):2801\u20132814","journal-title":"J Biol Chem"},{"key":"5519_CR26","doi-asserted-by":"crossref","unstructured":"Strazzella A, Ossoli A, Calabresi L (2021) High-density lipoproteins kidney. Cells 10(4)","DOI":"10.3390\/cells10040764"},{"issue":"40","key":"5519_CR27","doi-asserted-by":"publisher","first-page":"30719","DOI":"10.1074\/jbc.M110.131771","volume":"285","author":"I Mosialou","year":"2010","unstructured":"Mosialou I, Zannis VI, Kardassis D (2010) Regulation of human apolipoprotein m gene expression by orphan and ligand-dependent nuclear receptors. J Biol Chem 285(40):30719\u201330730","journal-title":"J Biol Chem"},{"issue":"12","key":"5519_CR28","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.2337\/diabetes.52.12.2989","volume":"52","author":"S Richter","year":"2003","unstructured":"Richter S et al (2003) Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels. Diabetes 52(12):2989\u20132995","journal-title":"Diabetes"},{"issue":"13","key":"5519_CR29","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1101\/gad.901601","volume":"15","author":"NJ Sund","year":"2001","unstructured":"Sund NJ et al (2001) Tissue-specific deletion of Foxa2 in pancreatic beta cells results in hyperinsulinemic hypoglycemia. Genes Dev 15(13):1706\u20131715","journal-title":"Genes Dev"},{"issue":"24","key":"5519_CR30","doi-asserted-by":"publisher","first-page":"16940","DOI":"10.1074\/jbc.M801930200","volume":"283","author":"C Wolfrum","year":"2008","unstructured":"Wolfrum C et al (2008) Foxa2 activity increases plasma high density lipoprotein levels by regulating apolipoprotein M. J Biol Chem 283(24):16940\u201316949","journal-title":"J Biol Chem"},{"key":"5519_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1476-511X-13-50","volume":"13","author":"JY Zhao","year":"2014","unstructured":"Zhao JY et al (2014) Dihydrocapsaicin down-regulates apoM expression through inhibiting Foxa2 expression and enhancing LXR\u03b1 expression in HepG2 cells. Lipids Health Dis 13:50","journal-title":"Lipids Health Dis"},{"issue":"12","key":"5519_CR32","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1073\/pnas.96.12.6660","volume":"96","author":"M Nitta","year":"1999","unstructured":"Nitta M et al (1999) CPF: an orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7alpha-hydroxylase gene. Proc Natl Acad Sci U S A 96(12):6660\u20136665","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"5519_CR33","doi-asserted-by":"publisher","first-page":"17793","DOI":"10.1074\/jbc.M000996200","volume":"275","author":"A del Castillo-Olivares","year":"2000","unstructured":"del Castillo-Olivares A, Gil G (2000) Alpha 1-fetoprotein transcription factor is required for the expression of sterol 12alpha -hydroxylase, the specific enzyme for cholic acid synthesis. Potential role in the bile acid-mediated regulation of gene transcription. J Biol Chem 275(23):17793\u201317799","journal-title":"J Biol Chem"},{"issue":"7","key":"5519_CR34","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1074\/jbc.M706382200","volume":"283","author":"N Venteclef","year":"2008","unstructured":"Venteclef N et al (2008) Regulation of anti-atherogenic apolipoprotein M gene expression by the orphan nuclear receptor LRH-1. J Biol Chem 283(7):3694\u20133701","journal-title":"J Biol Chem"},{"issue":"3","key":"5519_CR35","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S1097-2765(00)00050-2","volume":"6","author":"TT Lu","year":"2000","unstructured":"Lu TT et al (2000) Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6(3):507\u2013515","journal-title":"Mol Cell"},{"issue":"4","key":"5519_CR36","first-page":"3285","volume":"20","author":"L Yang","year":"2019","unstructured":"Yang L et al (2019) Niacin regulates apolipoprotein M expression via liver X receptor\u2013\u03b1. Mol Med Rep 20(4):3285\u20133291","journal-title":"Mol Med Rep"},{"issue":"1","key":"5519_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bbrc.2014.01.170","volume":"445","author":"G Luo","year":"2014","unstructured":"Luo G et al (2014) Palmitic acid suppresses apolipoprotein M gene expression via the pathway of PPAR\u03b2\/\u03b4 in HepG2 cells. Biochem Biophys Res Commun 445(1):203\u2013207","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"5519_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41419-025-07343-3","volume":"16","author":"Q Liu","year":"2025","unstructured":"Liu Q et al (2025) ApoM maintains cellular homeostasis between mitophagy and apoptosis by affecting the stability of Nnt mRNA through the Zic3-ApoM-Elavl2-Nnt axis during neural tube closure. Cell Death Dis 16(1):29","journal-title":"Cell Death Dis"},{"issue":"2","key":"5519_CR39","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11745-016-4227-9","volume":"52","author":"K Ren","year":"2017","unstructured":"Ren K et al (2017) TGF-\u03b2 down-regulates apolipoprotein M expression through the TAK-1-JNK-c-jun pathway in HepG2 cells. Lipids 52(2):109\u2013117","journal-title":"Lipids"},{"issue":"8","key":"5519_CR40","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1089\/dna.2015.2892","volume":"34","author":"JJ Gao","year":"2015","unstructured":"Gao JJ et al (2015) ApoM suppresses TNF-\u03b1-induced expression of ICAM-1 and VCAM-1 through inhibiting the activity of NF-\u03baB. DNA Cell Biol 34(8):550\u2013556","journal-title":"DNA Cell Biol"},{"issue":"2","key":"5519_CR41","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10753-017-0719-x","volume":"41","author":"B Zhu","year":"2018","unstructured":"Zhu B et al (2018) Apolipoprotein M protects against lipopolysaccharide-induced acute lung injury via sphingosine-1-phosphate signaling. Inflammation 41(2):643\u2013653","journal-title":"Inflammation"},{"issue":"4","key":"5519_CR42","first-page":"3117","volume":"22","author":"Y Shi","year":"2020","unstructured":"Shi Y et al (2020) Increased expression levels of inflammatory cytokines and adhesion molecules in lipopolysaccharide\u2013induced acute inflammatory apoM\u2013\/\u2013 mice. Mol Med Rep 22(4):3117\u20133126","journal-title":"Mol Med Rep"},{"issue":"4","key":"5519_CR43","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.bbrc.2004.06.180","volume":"321","author":"N Xu","year":"2004","unstructured":"Xu N et al (2004) Both leptin and leptin-receptor are essential for apolipoprotein M expression in vivo. Biochem Biophys Res Commun 321(4):916\u2013921","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"5519_CR44","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12944-017-0458-x","volume":"16","author":"J Wei","year":"2017","unstructured":"Wei J et al (2017) 17\u03b2-estradiol regulates the expression of apolipoprotein M through estrogen receptor \u03b1-specific binding motif in its promoter. Lipids Health Dis 16(1):66","journal-title":"Lipids Health Dis"},{"key":"5519_CR45","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/1476-511X-11-168","volume":"11","author":"Y Yi-zhou","year":"2012","unstructured":"Yi-zhou Y et al (2012) Dihydrotestosterone regulating apolipoprotein M expression mediates via protein kinase C in HepG2 cells. Lipids Health Dis 11:168","journal-title":"Lipids Health Dis"},{"issue":"2","key":"5519_CR46","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.bbalip.2006.02.002","volume":"1761","author":"N Xu","year":"2006","unstructured":"Xu N et al (2006) Down-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 cells. Biochim Biophys Acta 1761(2):256\u2013260","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"5519_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2013.03.002","volume":"533","author":"X Ma","year":"2013","unstructured":"Ma X et al (2013) Anti-inflammatory effects of propofol are mediated by apolipoprotein M in a hepatocyte nuclear factor-1\u03b1-dependent manner. Arch Biochem Biophys 533(1\u20132):1\u201310","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"5519_CR48","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s10753-014-0104-y","volume":"38","author":"X Ma","year":"2015","unstructured":"Ma X et al (2015) Propofol attenuates lipopolysaccharide-induced monocyte chemoattractant protein-1 production through enhancing apoM and foxa2 expression in HepG2 cells. Inflammation 38(3):1329\u20131336","journal-title":"Inflammation"},{"issue":"3","key":"5519_CR49","first-page":"510","volume":"29","author":"L Yang","year":"2012","unstructured":"Yang L, Zhao S (2012) Effect of simvastatin on the expression and regulation mechanism of apolipoprotein M. Int J Mol Med 29(3):510\u2013514","journal-title":"Int J Mol Med"},{"issue":"8","key":"5519_CR50","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1194\/jlr.M050021","volume":"55","author":"I Sutter","year":"2014","unstructured":"Sutter I et al (2014) Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate. J Lipid Res 55(8):1730\u20131737","journal-title":"J Lipid Res"},{"issue":"6","key":"5519_CR51","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/j.transproceed.2013.04.009","volume":"45","author":"XL Xu","year":"2013","unstructured":"Xu XL et al (2013) Urinary apolipoprotein M could be used as a biomarker of acute renal injury: an ischemia-reperfusion injury model of kidney in rat. Transpl Proc 45(6):2476\u20132479","journal-title":"Transpl Proc"},{"issue":"1","key":"5519_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1681\/ASN.2020050697","volume":"32","author":"Y Drexler","year":"2021","unstructured":"Drexler Y et al (2021) Sphingosine-1-phosphate metabolism and signaling in kidney diseases. J Am Soc Nephrol 32(1):9\u201331","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"5519_CR53","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1681\/ASN.2009060662","volume":"21","author":"A Bajwa","year":"2010","unstructured":"Bajwa A et al (2010) Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury. J Am Soc Nephrol 21(6):955\u2013965","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"5519_CR54","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1182\/blood-2012-11-467191","volume":"122","author":"G Zhang","year":"2013","unstructured":"Zhang G et al (2013) Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation. Blood 122(3):443\u2013455","journal-title":"Blood"},{"issue":"21","key":"5519_CR55","doi-asserted-by":"publisher","first-page":"14839","DOI":"10.1074\/jbc.M112.426726","volume":"288","author":"K Sobel","year":"2013","unstructured":"Sobel K et al (2013) Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling. J Biol Chem 288(21):14839\u201314851","journal-title":"J Biol Chem"},{"key":"5519_CR56","doi-asserted-by":"crossref","unstructured":"Wu J et al (2023) Sphingosine-1-phosphate receptor 3 induces endothelial barrier loss via ADAM10-mediated vascular endothelial-cadherin cleavage. Int J Mol Sci 24(22)","DOI":"10.3390\/ijms242216083"},{"issue":"9","key":"5519_CR57","doi-asserted-by":"publisher","first-page":"107693","DOI":"10.1016\/j.isci.2023.107693","volume":"26","author":"C Huang","year":"2023","unstructured":"Huang C et al (2023) Identification of S1PR4 as an immune modulator for favorable prognosis in HNSCC through machine learning. iScience 26(9):107693","journal-title":"iScience"},{"key":"5519_CR58","doi-asserted-by":"crossref","unstructured":"Evrard M et al (2022) Sphingosine 1-phosphate receptor 5 (S1PR5) regulates the peripheral retention of tissue-resident lymphocytes. J Exp Med 219(1)","DOI":"10.1084\/jem.20210116"},{"issue":"389","key":"5519_CR59","doi-asserted-by":"publisher","first-page":"ra79","DOI":"10.1126\/scisignal.aaa2581","volume":"8","author":"S Galvani","year":"2015","unstructured":"Galvani S et al (2015) HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. Sci Signal 8(389):ra79","journal-title":"Sci Signal"},{"issue":"53","key":"5519_CR60","doi-asserted-by":"publisher","first-page":"44645","DOI":"10.1074\/jbc.M112.423426","volume":"287","author":"BA Wilkerson","year":"2012","unstructured":"Wilkerson BA et al (2012) Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1. J Biol Chem 287(53):44645\u201344653","journal-title":"J Biol Chem"},{"issue":"1","key":"5519_CR61","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12944-017-0429-2","volume":"16","author":"M Ruiz","year":"2017","unstructured":"Ruiz M, Okada H, Dahlb\u00e4ck B (2017) HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium. Lipids Health Dis 16(1):36","journal-title":"Lipids Health Dis"},{"issue":"3","key":"5519_CR62","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.bbrc.2018.09.162","volume":"505","author":"W Pei","year":"2018","unstructured":"Pei W et al (2018) Deletion of ApoM gene induces apoptosis in mouse kidney via mitochondrial and endoplasmic reticulum stress pathways. Biochem Biophys Res Commun 505(3):891\u2013897","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"5519_CR63","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12944-017-0556-9","volume":"16","author":"L He","year":"2017","unstructured":"He L et al (2017) Characteristics of lipid metabolism including serum apolipoprotein M levels in patients with primary nephrotic syndrome. Lipids Health Dis 16(1):167","journal-title":"Lipids Health Dis"},{"key":"5519_CR64","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.atherosclerosis.2018.06.815","volume":"275","author":"IM S\u00f8rensen","year":"2018","unstructured":"S\u00f8rensen IM et al (2018) Apolipoprotein M in patients with chronic kidney disease. Atherosclerosis 275:304\u2013311","journal-title":"Atherosclerosis"},{"issue":"4","key":"5519_CR65","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1161\/ATVBAHA.124.322367","volume":"45","author":"JT Stadler","year":"2025","unstructured":"Stadler JT et al (2025) ApoM and major adverse cardiovascular events in chronic kidney disease: a prospective cohort study. Arterioscler Thromb Vasc Biol 45(4):496\u2013505","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5519_CR66","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejphar.2017.03.053","volume":"816","author":"C Christoffersen","year":"2017","unstructured":"Christoffersen C et al (2017) ApoB and apoM - new aspects of lipoprotein biology in uremia-induced atherosclerosis. Eur J Pharmacol 816:154\u2013160","journal-title":"Eur J Pharmacol"},{"key":"5519_CR67","doi-asserted-by":"publisher","first-page":"1825849","DOI":"10.1155\/2019\/1825849","volume":"2019","author":"J Wu","year":"2019","unstructured":"Wu J et al (2019) Apolipoprotein M serum levels correlate with IgA vasculitis and IgA vasculitis nephritis. Dis Markers 2019:1825849","journal-title":"Dis Markers"},{"issue":"8","key":"5519_CR68","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.2337\/db21-0920","volume":"71","author":"NL Baker","year":"2022","unstructured":"Baker NL et al (2022) Plasma apoM levels and progression to kidney dysfunction in patients with type 1 diabetes. Diabetes 71(8):1795\u20131799","journal-title":"Diabetes"},{"key":"5519_CR69","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.trsl.2023.02.004","volume":"258","author":"M Kurano","year":"2023","unstructured":"Kurano M et al (2023) Apolipoprotein M\/sphingosine 1-phosphate protects against diabetic nephropathy. Transl Res 258:16\u201334","journal-title":"Transl Res"},{"issue":"4","key":"5519_CR70","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.ekir.2023.01.031","volume":"8","author":"Y Drexler","year":"2023","unstructured":"Drexler Y et al (2023) Identification of glomerular and plasma apolipoprotein M as novel biomarkers in glomerular disease. Kidney Int Rep 8(4):884\u2013897","journal-title":"Kidney Int Rep"},{"key":"5519_CR71","doi-asserted-by":"publisher","first-page":"15018","DOI":"10.1038\/nrdp.2015.18","volume":"1","author":"MC Thomas","year":"2015","unstructured":"Thomas MC et al (2015) Diabetic kidney disease. Nat Rev Dis Primers 1:15018","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"5519_CR72","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3892\/mmr_00000245","volume":"3","author":"M Matsuyama","year":"2010","unstructured":"Matsuyama M et al (2010) Expression of sphingosine-1 phosphate receptor in rat renal ischemia-reperfusion injury. Mol Med Rep 3(2):233\u2013236","journal-title":"Mol Med Rep"},{"issue":"12","key":"5519_CR73","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/ki.2011.281","volume":"80","author":"SW Park","year":"2011","unstructured":"Park SW et al (2011) Sphingosine kinase 1 protects against renal ischemia-reperfusion injury in mice by sphingosine-1-phosphate1 receptor activation. Kidney Int 80(12):1315\u20131327","journal-title":"Kidney Int"},{"issue":"4","key":"5519_CR74","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1681\/ASN.2013121351","volume":"26","author":"A Bajwa","year":"2015","unstructured":"Bajwa A et al (2015) Sphingosine 1-phosphate receptor-1 enhances mitochondrial function and reduces cisplatin-induced tubule injury. J Am Soc Nephrol 26(4):908\u2013925","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"5519_CR75","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1681\/ASN.2011050503","volume":"23","author":"SW Park","year":"2012","unstructured":"Park SW et al (2012) Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 23(2):266\u2013280","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"5519_CR76","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1096\/fj.201801748R","volume":"33","author":"M Kurano","year":"2019","unstructured":"Kurano M et al (2019) Apolipoprotein M suppresses the phenotypes of IgA nephropathy in hyper-IgA mice. Faseb j 33(4):5181\u20135195","journal-title":"Faseb j"},{"key":"5519_CR77","doi-asserted-by":"crossref","unstructured":"Tolerico M et al (2025) Modulation of the apolipoprotein M\/S1PR4 pathway reduces podocyte lipid overload in alport syndrome via distinct autophagy and efflux mechanisms. J Am Soc Nephrol","DOI":"10.1681\/ASN.0000000996"},{"issue":"1","key":"5519_CR78","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13075-019-1890-2","volume":"21","author":"H Tyd\u00e9n","year":"2019","unstructured":"Tyd\u00e9n H et al (2019) Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus. Arthritis Res Ther 21(1):110","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"5519_CR79","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.devcel.2020.05.024","volume":"53","author":"BS Ding","year":"2020","unstructured":"Ding BS et al (2020) Aging suppresses sphingosine-1-phosphate chaperone ApoM in circulation resulting in maladaptive organ repair. Dev Cell 53(6):677\u2013690e4","journal-title":"Dev Cell"},{"key":"5519_CR80","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2017.08.005","volume":"265","author":"MH Bosteen","year":"2017","unstructured":"Bosteen MH et al (2017) Effects of apolipoprotein M in uremic atherosclerosis. Atherosclerosis 265:93\u2013101","journal-title":"Atherosclerosis"},{"key":"5519_CR81","doi-asserted-by":"crossref","unstructured":"Gerdanovics CA et al (2025) Adipokines and vascular modulators in CKM: emerging biomarkers as diagnostic and therapeutic targets. Int J Mol Sci 26(22)","DOI":"10.3390\/ijms262211083"},{"key":"5519_CR82","doi-asserted-by":"publisher","first-page":"109642","DOI":"10.1016\/j.abb.2023.109642","volume":"743","author":"T Xu","year":"2023","unstructured":"Xu T et al (2023) ApoM suppresses kidney renal clear cell carcinoma growth and metastasis via the hippo-YAP signaling pathway. Arch Biochem Biophys 743:109642","journal-title":"Arch Biochem Biophys"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05519-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05519-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05519-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:03:41Z","timestamp":1784282621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05519-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":82,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["5519"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05519-9","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript does not involve experiments on humans or animals, and therefore does not require ethical approval or participant consent.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the publication of this manuscript.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}